SIRCO INTERNATIONAL CORP
NT 10-K, 1998-02-27
LEATHER & LEATHER PRODUCTS
Previous: SHARED MEDICAL SYSTEMS CORP, S-3, 1998-02-27
Next: SMITH BARNEY FUNDS INC, 485APOS, 1998-02-27



================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549




                                   FORM 12b-25


                           NOTIFICATION OF LATE FILING
                                       of

                                    FORM 10-K
                       For Period Ended: November 30, 1997



                            SIRCO INTERNATIONAL CORP.
                            -------------------------
                              (Name of Registrant)



              24 Richmond Hill Avenue, Stamford, Connecticut 06901
              ---------------------------------------------------- 
                     (Address of Principal Executive Office)



                                     0-4465
                            ------------------------ 
                            (Commission File Number)




                Nothing in this form shall be construed to imply
                that the Commission has verified any information
                                contained herein.

















                                   Page 1 of 4
<PAGE>
Part II - Rules 12b-25(b) and (c)

         If the subject report could not be filed without unreasonable effort or
expense  and  the  registrant  seeks  relief  pursuant  to Rule  12b-25(b),  the
following should be completed: (Check appropriate box.)

         [X]      (a)      The reasons described in reasonable detail in Part
                           III of this form could not be eliminated without
                           unreasonable effort or expense;

         [X]      (b)      The subject annual report on Form 10-K will be 
                           filed on or before the fifteenth calendar day
                           following the prescribed due date; and

         [ ]      (c)      The accountant's statement or other exhibit required
                           by Rule 12b-25(c) has been attached if applicable.


Part III - Narrative

         State below in reasonable detail the reasons why Form 10-K could not be
filed within the prescribed period.


               The Company's  preparation  of its Annual Report on Form 10-K for
         the fiscal  year  ended  November  30,  1997,  has been  delayed as the
         Company  is  unable  to  complete  its  financial  statements,  and the
         Company's independent accountants are unable to complete their audit of
         such financial statements,  until such time as the Company receives the
         audited financial  statements of CLEC Holding Corp.  ("CLEC" Holding"),
         from whom the  Company  acquired  3,000,000  shares of common  stock as
         described in the Company's Current Report on Form 8-K dated October 22,
         1997.  The Company has been  advised by CLEC  Holding  that the audited
         financial  statements  of CLEC Holding will be furnished to the Company
         on or about March 10, 1998.

               As a result of the foregoing, the Company's Annual Report on Form
         10-K for the year ended  November  30, 1997,  cannot be  completed  and
         timely filed without unreasonable effort or expense.



















                                   Page 2 of 4
<PAGE>
Part IV - Other Information


         (1)  Name and  telephone  number of person to contact in regard to this
              notification.

              Eric M. Hellige                                     (212) 421-4100
              ------------------------------------------------------------------

         (2)  Have all other periodic reports required under Section 13 or 15(d)
              of the  Securities  Exchange  Act of  1934  or  Section  30 of the
              Investment  Company Act of 1940 during the preceding twelve months
              or for such  shorter  period that the  registrant  was required to
              file such report(s) been filed? If the answer is no, identify such
              reports.

                           Yes [X]                   No [ ] 


         (3)  Is it  anticipated  that any  significant  change  in  results  of
              operations from the corresponding  period for the last fiscal year
              will be reflected by the earnings statements to be included in the
              subject report or portion thereof? If so, attach an explanation of
              the anticipated change, both narratively and quantitatively,  and,
              if  appropriate,  state the reasons why a  reasonable  estimate of
              results cannot be made.

                           Yes [X]                   No [ ]



         The  Company has  experienced  a  significant  change in its results of
         operations in fiscal 1997 as compared to fiscal 1996. The Company's net
         loss for fiscal 1997 is  approximately  $2,668,000,  as compared to net
         income  in  fiscal  1996 of  approximately  $622,000.  This  change  in
         operating  results is due to a significant  deterioration  in net sales
         for fiscal year 1997, which decreased by  approximately  $11,738,000 to
         approximately  $16,008,000  as  compared to  approximately  $27,746,000
         reported in fiscal 1996. Net sales for the Company's  United States and
         Canadian   operations   decreased  in  fiscal  1997  by   approximately
         $6,450,000 and $5,288,000,  respectively,  from amounts reported in the
         prior fiscal year. This decline in net sales is primarily  attributable
         to three  developments:  the Company's loss of the license to sell FILA
         product  (see below) in the United  States,  effective in June of 1996;
         the Company's loss of the license to sell Airway product (see below) in
         Canada, effective December 1996; and a decrease in demand in the United
         States for the  Company's  other mature  brand  names.  This decline in
         sales was  partially  offset by sales growth in new licenses  that were
         signed in 1996 for the Perry Ellis and Hedgren  brand names.  Sales per
         brand name for the two years were as follows:








                                  Page 3 of 4
<PAGE>
                                                                      Increase/
                                       1997             1996         (Decrease)
                                   -----------      -----------    ------------

Perry Ellis and Hedgren            $ 3,443,000      $   206,000    $  3,237,000
FILA                                         0        8,584,000      (8,584,000)
Airway                                 472,000        5,782,000      (5,310,000)
Other brand names                    6,665,000        8,830,000      (2,165,000)
                                   -----------      -----------    ------------
Total brand names                   10,580,000       23,402,000     (12,822,000)
Unlicensed product                   5,428,000        4,344,000       1,084,000
                                   -----------      -----------    ------------
Total sales                        $16,008,000      $27,746,000    $(11,738,000)


         The Company's  gross profit for fiscal 1997 decreased by  approximately
         $4,683,000 to approximately $2,405,000 from approximately $7,088,000 in
         fiscal 1996,  and the gross profit  percentage in fiscal 1997 decreased
         to 15.0%  from  25.5% in fiscal  1996.  The  decrease  in gross  profit
         percentage  is  primarily  attributable  to the lack of a  sufficiently
         large  revenue base over which to spread fixed costs and to a change in
         product  mix.  The change in  product  mix has two  components.  First,
         fiscal 1997 sales contained a higher percentage of unlicensed products,
         which  traditionally  have a lower  gross  profit  margin,  and second,
         fiscal  1997 sales  contained  the new brand  names of Perry  Ellis and
         Hedgren,  as compared to the established brand names of FILA and Airway
         in fiscal  1996.  Established  products  with  brand  names are able to
         demand a higher gross  margin than new products  with brand names which
         are vying for shelf space with other new products from competitors.

         SIRCO  INTERNATIONAL CORP. has caused this notification to be signed on
its behalf by the undersigned thereunto duly authorized.



Date: February 27, 1998                          By: /s/Joel Dupre
                                                     ------------- 
                                               Name: Joel Dupre
                                              Title: Chairman of the Board
                                                     and Chief Executive Officer


















                                   Page 4 of 4


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission